Biograil

€20.0M Unknown stage

Announced: Nov 4, 2026
Sector: Biotechnology
Investors: 4

Summary

Biograil raised €20 million to advance its oral drug-delivery technology toward clinical trials. Biograil is an oral drug-delivery technology developer.

Investors

Verve Ventures, Megatrend Invest, HTGF Opportunity, High-Tech Gründerfonds